Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
In preclinical and cell culture research, KPV demonstrates suppression of pro-inflammatory cytokines IL-6, IL-1, and TNF- through melanocortin receptor pathway activation
- Most evidence comes from animal studies - Human data is extremely limited - No FDA approval for orthopedic use - Clinical benefit in musculoskeletal conditions remains unproven While the biology is interesting, potential does not equal proven clinical outcomes
HEALTH CANADA WARNING Unauthorized health products have not been approved by Health Canada, which means that they have not been assessed for safety, efficacy and quality and may pose a range of serious health risks
Responsive support, dependable availability, and resources developed specifically for healthcare practices
US$ 22.67
US$ 21.37
US$ 25.37
US$ 20.14
US$ 27.68
